KRAS is one of the most explored genes frequently mutated in colorectal neoplasia; its mutation frequency varies from 20% to 70% in colorectal adenomas [67], and approx. 40–52% of CRC cases bear KRAS mutation [68]. This evidence concerns the gene KRAS and colorectal carcinoma.